Discover the full record of transactions filed by Harrigan Edmund, 董事. Director active across 3 companies, notably INCYTE CORP. Cumulatively, 32 disclosures have been published. Activity tracked since 26 May 2021. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Harrigan Edmund
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
HARRIGAN EDMUND is Administrateur at INCYTE CORP, Acadia Pharmaceuticals INC and PhaseBio Pharmaceuticals Inc. He has 32 filings in total, and across the 32 sampled filings between 2021-05-28 and 2026-06-10, the most common transaction nature is Attribution, with sum_buy_eur at 0 and sum_sell_eur at 0.